Physician profile
Kenneth D Lessans
NPI 1992736169
$14,872.17
in general payments reported to CMS, 2019-2025
53 companies · $2,535 in 2025
The $2,535 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $337 · 2021: $1,548 · 2022: $2,233 · 2023: $2,238 · 2024: $5,008 · 2025: $2,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,582 · Consulting Fee: $2,180 · Entertainment: $18.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,582.32 |
| Consulting Fee | $2,180.00 |
| Entertainment | $18.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,640.30 | 2019-2025 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $1,797.23 | 2019-2025 | Provenge |
| Astrazeneca Pharmaceuticals LP | $1,386.36 | 2019-2025 | Lynparza |
| Astellas Pharma US INC | $1,225.20 | 2019-2025 | Xtandi, Padcev, Myrbetriq |
| Merck Sharp & Dohme LLC | $898.23 | 2020-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Sumitomo Pharma America, INC. | $764.21 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $596.59 | 2019-2025 | |
| Axonics, INC. | $476.34 | 2020-2024 | Axonics |
| Urovant Sciences INC | $429.26 | 2021-2022 | |
| Procept Biorobotics Corporation | $400.22 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Ferring Pharmaceuticals INC. | $388.72 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $379.87 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $372.66 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $295.64 | 2021-2024 | Prolaris |
| Immunitybio, INC. | $294.37 | 2024-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $289.46 | 2021-2025 | Interstim, Biosyn |
| Urogen Pharma, INC. | $262.16 | 2021-2025 | Jelmyto |
| Coloplast Corp | $232.72 | 2022-2024 | Speedicath |
| Allergan, INC. | $162.15 | 2019-2022 | |
| Teleflex LLC | $124.08 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $109.59 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $101.18 | 2022-2025 | |
| Verity Pharmaceuticals INC. | $100.01 | 2022-2024 | Trelstar |
| Travere Therapeutics, INC. | $94.29 | 2019-2021 | |
| Neotract INC. | $91.44 | 2019 | |
| Accord Healthcare, INC. | $90.11 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $86.10 | 2023-2025 | Pylarify |
| Telix Pharmaceuticals | $86.07 | 2024-2025 | Illuccix |
| Blue Earth Diagnostics | $64.72 | 2021-2023 | |
| Myovant Sciences INC. | $64.57 | 2021-2022 | |
| Baxter Healthcare | $53.62 | 2021-2024 | Perclot |
| Foundation Medicine, INC. | $47.39 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $41.91 | 2019-2022 | |
| Rochester Medical Corporation | $40.64 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $39.95 | 2021-2022 | |
| Therapeuticsmd, INC. | $38.38 | 2019-2020 | |
| Sanara Medtech INC. | $34.67 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $33.87 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Caldera Medical, INC | $30.13 | 2021 | |
| Tolmar, INC. | $28.78 | 2023 | |
| Antares Pharma, INC. | $22.02 | 2021 | |
| Bluewind Medical | $19.39 | 2024 | Revi |
| Provepharm INC. | $18.93 | 2024 | Bludigo |
| Photocure INC | $18.67 | 2021 | |
| Ethicon US, LLC | $18.59 | 2025 | Stratafix, Echelon Flex, Monocryl |
| Abc Home Medical Supply, INC. | $18.01 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $17.38 | 2023 | Bard Urinary Drainage Bag |
| Hollister Incorporated | $13.13 | 2021 | |
| Olympus America INC. | $13.09 | 2021 | |
| Alnylam Pharmaceuticals INC. | $13.00 | 2022 | |
| Valencia Technologies Corporation | $6.77 | 2025 | Ecoin Device Kit |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Lessans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.